Selling Contract Development and Manufacturing Organisation (CDMO) services is a complex task that demands a versatile skill set, encompassing drug development e...

With targeted delivery and potential for improved patient adherence, inhaled mRNA therapies are emerging as the new frontier in respiratory and genetic medicine....

The pressure to reduce greenhouse gas emissions has transformed nearly every industry, and respiratory pharmaceuticals is no exception. Pressurised metered d...

Nasal drug delivery has traditionally been used for local, inflammatory conditions within the sinus cavity, such as rhinitis and nasal congestion. In recent year...

With the objective to providing more efficient and user-friendly solutions for inhalation therapy, companies developing mesh nebulisers have adopted customisable pla...

Nasal drug delivery has emerged as a major focus in pharmaceutical development because it combines convenience, rapid absorption, high bioavailability, and the p...

Counterfeiting is no longer a crude affair. Today’s fake products can closely mimic legitimate ones, infiltrating supply chains with concerning precision. Yet, for a...

Global distribution of life-saving pharmaceuticals is incredibly complex, with several different components from warehouse to final delivery. At each stage, provider...

Sustainability initiatives have brought the problematic carbon footprint of propellants in pressurised Metered Dose Inhalers (pMDIs) into sharp relief. A shift to lo...

The pharmaceutical inhalation industry stands at a pivotal crossroads. After decades of relative stability following the phase-out of CFCs in the 1990s, a second maj...